SCHEMBL15224261

SCHEMBL15224261

CCNC(=O)c1ccc(=O)n(C)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CREBBP Q92793 1/20 0.50
BRD4 O60885 4/20 0.49
KMT2A Q03164 4/20 0.46
MEN1 O00255 3/20 0.46
HTT P42858 3/20 0.46
ALDH1A1 P00352 5/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
HPGD P15428 3/20 0.44
LMNA P02545 2/20 0.44
RAB9A P51151 2/20 0.44
MAPT P10636 1/20 0.44
GAA P10253 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C19 P33261 1/20 0.44
KDM4E B2RXH2 3/20 0.42
TDP1 Q9NUW8 1/20 0.42
NPC1 O15118 1/20 0.41
MITF O75030 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CA12 O43570 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6533268 0.83 LMNA (0.48) CREBBPBRD4KMT2AMEN1HTT
SCHEMBL2896747 0.82 CREBBP (0.52) CREBBPBRD4KMT2AMEN1HTT
SCHEMBL2736608 0.81 ALDH1A1 (0.59) CREBBPBRD4KMT2AMEN1ALDH1A1
SCHEMBL13702366 0.80 BRD4 (0.54) CREBBPBRD4KMT2AMEN1HTT
SCHEMBL22479631 0.79 CREBBP (0.52) CREBBPBRD4KMT2AMEN1HTT
SCHEMBL5909057 0.77 CA12 (0.58) KMT2AMEN1ALDH1A1HPGDLMNA
SCHEMBL13702264 0.76 EPHX2 (0.68) BRD4KMT2AHTTALDH1A1SMN1; SMN2
SCHEMBL13702317 0.76 KCNH2 (0.51) BRD4KMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL13702326 0.76 EPHX2 (0.50) BRD4HTTALDH1A1SMN1; SMN2HPGD
SCHEMBL13701809 0.76 CREBBP (0.50) CREBBPKMT2AMEN1HTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8524774-B1 Topical two step polytherapy for treatment of psoriasis and other skin disorders CYMBIOTICS, INC. (US) 2013-09-03 US claimed
US-8524774-B1 Topical two step polytherapy for treatment of psoriasis and other skin disorders CYMBIOTICS, INC. (US) 2013-09-03 US disclosed